Moreover, another metabolic advantage promoted by KRAS is the synthesis of monomeric constituents essential for cancer cell proliferation, namely amino acids, and nucleic acids, by deviating glucose toward anabolic pathways, including the pentose phosphate pathway [271]. This evidence concerns the gene KRAS and cancer.